Technical Analysis for RCEL - Avita Medical Limited

Grade Last Price % Change Price Change
D 19.14 -0.67% -0.13
RCEL closed down 1.33 percent on Friday, July 23, 2021, on 36 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical RCEL trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish -0.67%
Inside Day Range Contraction -2.00%
50 DMA Support Bullish -3.48%
Crossed Above 50 DMA Bullish -1.39%
Expansion Pivot Buy Setup Bullish Swing Setup -1.39%
Oversold Stochastic Weakness -1.39%
Stochastic Buy Signal Bullish 1.48%
Down 3 Days in a Row Weakness 1.48%
Down 4 Days in a Row Weakness 1.48%
Down 5 Days in a Row Weakness 1.48%
Older End-of-Day Signals for RCEL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
50 DMA Support 3 days ago
10 DMA Support 3 days ago
Down 3% 3 days ago
Down 2 % 3 days ago
Down 1% 3 days ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Avita Medical Limited Description

Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients 18 years and older. The company has a preclinical research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa. The company is based in Valencia, California.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Rare Diseases Clinical Research Wound Suspension Dermatology Regenerative Medicine Injuries Platform Technology Burns Aesthetics Genodermatoses Treatment Solutions Epidermolysis Bullosa Skin Chronic Wound Chronic Wounds

Is RCEL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 29.34
52 Week Low 16.87
Average Volume 185,340
200-Day Moving Average 21.39
50-Day Moving Average 19.30
20-Day Moving Average 19.86
10-Day Moving Average 19.32
Average True Range 0.66
ADX 15.82
+DI 23.97
-DI 30.72
Chandelier Exit (Long, 3 ATRs) 20.50
Chandelier Exit (Short, 3 ATRs) 20.54
Upper Bollinger Bands 21.39
Lower Bollinger Band 18.32
Percent B (%b) 0.31
BandWidth 15.42
MACD Line -0.14
MACD Signal Line -0.06
MACD Histogram -0.0767
Fundamentals Value
Market Cap 416.68 Million
Num Shares 21.6 Million
EPS -0.03
Price-to-Earnings (P/E) Ratio -669.10
Price-to-Sales 29.98
Price-to-Book 7.58
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.13
Resistance 3 (R3) 20.11 19.81 19.98
Resistance 2 (R2) 19.81 19.59 19.82 19.94
Resistance 1 (R1) 19.54 19.46 19.39 19.56 19.89
Pivot Point 19.24 19.24 19.16 19.25 19.24
Support 1 (S1) 18.97 19.02 18.82 18.98 18.65
Support 2 (S2) 18.67 18.89 18.68 18.60
Support 3 (S3) 18.40 18.67 18.56
Support 4 (S4) 18.41